4.15
price up icon2.47%   0.10
after-market Handel nachbörslich: 4.19 0.04 +0.96%
loading

Cingulate Inc Aktie (CING) Neueste Nachrichten

pulisher
Oct 14, 2025

Why Cingulate Inc. stock could be next big winnerJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Will Cingulate Inc. continue its uptrend2025 Analyst Calls & Fast Moving Market Watchlists - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Cingulate receives target date for when it could receive FDA approval - The Business Journals

Oct 14, 2025
pulisher
Oct 14, 2025

FDA accepts Cingulate’s ADHD drug application, sets May 2026 target date - Investing.com Australia

Oct 14, 2025
pulisher
Oct 14, 2025

Cingulate Inc’s NDA for CTx-1301 Accepted by FDA - TipRanks

Oct 14, 2025
pulisher
Oct 14, 2025

Cingulate announces FDA accepted for review the NDA for CTx-1301 - TipRanks

Oct 14, 2025
pulisher
Oct 14, 2025

Cingulate Inc FDA Accepts NDA for CTx-1301 for ADHD - TradingView

Oct 14, 2025
pulisher
Oct 14, 2025

FDA Accepts Cingulate’s New Drug Application for CTx-1301 - GlobeNewswire

Oct 14, 2025
pulisher
Oct 14, 2025

FDA Accepts Cingulate’s New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026 PDUFA Date - Stock Titan

Oct 14, 2025
pulisher
Oct 14, 2025

What’s next for Cingulate Inc. stock priceJuly 2025 Opening Moves & Entry and Exit Point Strategies - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Will Cingulate Inc. bounce back from current support2025 Retail Activity & Verified Entry Point Signals - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Will Cingulate Inc. stock remain a Wall Street favorite2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Can Cingulate Inc. Equity Warrant stock deliver consistent earnings growth2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What institutional flow reveals about Cingulate Inc.Earnings Recap Report & Low Risk Entry Point Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How Cingulate Inc. Equity Warrant stock trades before earningsWatch List & Daily Market Momentum Tracking - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How supply chain issues affect Cingulate Inc. stockOil Prices & Consistent Growth Equity Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Backtesting results for Cingulate Inc. Equity Warrant trading strategiesOil Prices & Consistent Growth Equity Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Can Cingulate Inc. stock deliver consistent earnings growthTrade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is it too late to sell Cingulate Inc.Quarterly Growth Report & AI Forecast for Swing Trade Picks - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Is Cingulate Inc a good long term investmentREITs Market Trends & Rapid Portfolio Strategies - earlytimes.in

Oct 12, 2025
pulisher
Oct 12, 2025

Cingulate Inc. (NASDAQ:CING) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Oct 12, 2025
pulisher
Oct 11, 2025

Is Cingulate Inc. stock entering bullish territoryCEO Change & Smart Money Movement Alerts - newser.com

Oct 11, 2025
pulisher
Oct 11, 2025

Analyzing drawdowns of Cingulate Inc. Equity Warrant with statistical tools2025 Year in Review & Stock Timing and Entry Methods - newser.com

Oct 11, 2025
pulisher
Oct 10, 2025

How Cingulate Inc. stock compares to industry benchmarksQuarterly Trade Summary & Weekly Top Gainers Trade List - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Market reaction to Cingulate Inc.’s recent newsDividend Hike & Consistent Income Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Cingulate Inc. a candidate for recovery playInsider Selling & Weekly Chart Analysis and Guides - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Cingulate Inc. stock bottoming outJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Cingulate Inc. stock retracement – recovery analysisTrade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What does recent volatility data suggest for Cingulate Inc.Trade Analysis Report & Verified Swing Trading Watchlist - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Using flow based indicators on Cingulate Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Will Cingulate Inc. stock gain from government policiesJuly 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Understanding Cingulate Inc. Equity Warrant’s price movementQuarterly Profit Summary & Precise Buy Zone Identification - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Real time breakdown of Cingulate Inc. Equity Warrant stock performanceJuly 2025 Retail & Technical Confirmation Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Tools to monitor Cingulate Inc. Equity Warrant recovery probability - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

What drives Cingulate Inc Equity Warrant stock priceSupport Zone Identification & The Smart Money Is Buying These Picks - earlytimes.in

Oct 04, 2025
pulisher
Oct 04, 2025

Torrent Pharmaceuticals Limited (500420) Hits 52 Week HighMomentum Trading Signals & Low Risk Wealth Plans - earlytimes.in

Oct 04, 2025
pulisher
Oct 03, 2025

Can trapped investors hope for a rebound in Cingulate Inc.Insider Buying & Safe Capital Allocation Plans - newser.com

Oct 03, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):